Taysha Gene Therapies Inc (TSHA)
Stock-Based Compensation
$18.17M
TTM · Period ending: · USD
TSHA Stock-Based Compensation
Latest reported$18.17Mperiod ending
Latest reported$18.17Mperiod ending
TSHA Stock-Based Comp ($0.00 → $18.17M)
Annual stock-based compensation
High-resolution chart · PNG
TSHA stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 13,298,000 | |
| 13,103,000 | |
| 7,905,000 | |
| 18,043,000 | |
| 18,184,000 | |
| 3,354,000 | |
| 0 |